↓ Skip to main content

Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer

Overview of attention for article published in Breast Cancer Research, May 2020
Altmetric Badge

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer
Published in
Breast Cancer Research, May 2020
DOI 10.1186/s13058-020-01294-7
Pubmed ID
Authors

Lori J. Goldstein, Raymond P. Perez, Denise Yardley, Linda K. Han, James M. Reuben, Hui Gao, Susan McCanna, Beth Butler, Pier Adelchi Ruffini, Yi Liu, Roberto R. Rosato, Jenny C. Chang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 22%
Student > Ph. D. Student 1 11%
Researcher 1 11%
Unknown 5 56%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 44%
Unknown 5 56%